These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 34481450)
1. [Serotonin-norepinephrine reuptake inhibitors in psychiatry and neurology]. Sivolap YP Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):141-146. PubMed ID: 34481450 [TBL] [Abstract][Full Text] [Related]
2. Further strategies for treating fibromyalgia: the role of serotonin and norepinephrine reuptake inhibitors. Mease PJ Am J Med; 2009 Dec; 122(12 Suppl):S44-55. PubMed ID: 19962496 [TBL] [Abstract][Full Text] [Related]
3. Treatment of comorbid pain with serotonin norepinephrine reuptake inhibitors. Briley M; Moret C CNS Spectr; 2008 Jul; 13(7 Suppl 11):22-6. PubMed ID: 18622371 [TBL] [Abstract][Full Text] [Related]
5. Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine. Trivedi MH; Desaiah D; Ossanna MJ; Pritchett YL; Brannan SK; Detke MJ Int Clin Psychopharmacol; 2008 May; 23(3):161-9. PubMed ID: 18408530 [TBL] [Abstract][Full Text] [Related]
6. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Arnold LM Pain Med; 2007 Sep; 8 Suppl 2():S63-74. PubMed ID: 17714117 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder. Schatzberg AF J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654 [TBL] [Abstract][Full Text] [Related]
8. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs. Mandrioli R; Protti M; Mercolini L Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591 [TBL] [Abstract][Full Text] [Related]
13. New developments in the neurobiological basis of anxiety disorders. Gorman JM; Hirschfeld RM; Ninan PT Psychopharmacol Bull; 2002; 36 Suppl 2():49-67. PubMed ID: 12490823 [TBL] [Abstract][Full Text] [Related]
14. Serotonin and noradrenaline reuptake inhibitors in animal models of pain. Mochizucki D Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S15-9. PubMed ID: 15378668 [TBL] [Abstract][Full Text] [Related]
15. Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials. Bradley AJ; Lenox-Smith AJ J Psychopharmacol; 2013 Aug; 27(8):740-58. PubMed ID: 23832963 [TBL] [Abstract][Full Text] [Related]
17. Other Antidepressants. Schwasinger-Schmidt TE; Macaluso M Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544 [TBL] [Abstract][Full Text] [Related]
18. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]. Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113 [TBL] [Abstract][Full Text] [Related]
19. Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics. Park P; Caballero J; Omidian H Ann Pharmacother; 2014 Jan; 48(1):86-92. PubMed ID: 24259607 [TBL] [Abstract][Full Text] [Related]
20. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]